Out of 2238 patients with breast cancer 35 developed carcinoma of the
contralateral breast. Thirty-three developed metachronous tumours whil
e two developed synchronous tumours. The thirty-five patients were fol
lowed up for periods between 4-8 years. The majority of patients belon
ged to the fourth decade and the peak incidence of developing a metach
ronous tumour occurred three to five years after diagnosis of the firs
t primary. T2 lesions were the most frequent initial primaries and N1
lesions were commoner than N2. IDC was the commonest histopathological
subtype. The overall two-year survival rate was 57.1% (20/35).